Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference
26 Julho 2023 - 9:00AM
Business Wire
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or
the “Company”), The Protein Sequencing CompanyTM, today announced
that it will be participating in the Canaccord Genuity 43rd Annual
Growth Conference taking place at the InterContinental Boston Hotel
on August 7-10, 2023.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, will
participate in the panel discussion “The Next Generation of
Proteomics from the Research and Clinical Perspectives” on
Thursday, August 10, at 10:00 AM ET.
Additionally, Jeff Hawkins will participate in a fireside chat
on Thursday, August 10, at 12:30 PM ET.
A live and archived webcast of the event will be available in
the “Investors” section of the Quantum-Si website under Events
& Presentations.
About Quantum-Si Incorporated Quantum-Si, The Protein
Sequencing CompanyTM, is focused on revolutionizing the growing
field of proteomics. The Company's suite of technologies is powered
by a first-of-its-kind semiconductor chip designed to enable
next-generation single-molecule protein sequencing and digitize
proteomic research in order to advance drug discovery and
diagnostics beyond what has been possible with DNA sequencing.
Learn more at www.quantum-si.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230726447394/en/
Investor Juan Avendano ir@quantum-si.com
Media Michael Sullivan media@quantum-si.com
Quantum Si (NASDAQ:QSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Quantum Si (NASDAQ:QSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024